OxIGen: Oxford Imagery Generation: Investigating the Effects of an Internet Based Computer Program in Depression (OxIGen)

January 8, 2014 updated by: University of Oxford
This research study is designed to investigate the effects of an online computer program, called OxIGen (Oxford Imagery Generation), on thinking style and mood in depression. The OxIGen program will be delivered online over four weeks and with follow-up at one, three and six months. This will inform potential future development of this computerized task into an online intervention to modify negative thinking styles in depression.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

150

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cambridgeshire
      • Cambridge, Cambridgeshire, United Kingdom, CB2 7EF
        • MRC Cognition and Brain Sciences Unit
    • Oxfordshire
      • Oxford, Oxfordshire, United Kingdom, OX3 7JX
        • Department of Psychiatry, University of Oxford

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Willing and able to give consent to the study
  • Male or Female, aged between 18 and 65 years
  • Current Major Depressive Episode (assessed by semi-structured clinical interview)
  • Access to internet in order to complete the online program
  • Able to travel to research centre for assessment appointments
  • Fluent in written and spoken English

Exclusion Criteria:

  • Meets criteria for current psychotic disorder
  • History of mania or hypomania as assessed by semi-structured clinical interview, or has elsewhere received a diagnosis of Bipolar disorder
  • Antidepressant medication begun or changed in dosage during last month
  • Meets criteria for current substance abuse disorder
  • Involved in other current treatment trials
  • Currently receiving psychological therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: OxIGen program
Internet based intervention taking place over 4 weeks
Internet-based intervention with 12 sessions over 4 weeks
Placebo Comparator: OxIGen: control version
A control version of the internet-based OxIGen intervention
A control version of the OxIGen internet-based intervention (i.e. identical but with putative active components removed)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change in score on Beck Depression Inventory - II
Time Frame: Baseline and post-intervention (4 weeks)
Baseline and post-intervention (4 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in score on Quick Inventory of Depressive Symptoms - Self Report
Time Frame: Baseline and post-intervention (4 weeks)
Baseline and post-intervention (4 weeks)
Change in State-Trait Anxiety Inventory (Trait scale)
Time Frame: Baseline and Post-Intervention (4 weeks)
Baseline and Post-Intervention (4 weeks)
Change on Beck Anxiety Inventory
Time Frame: Baseline and Post-Intervention (4 weeks)
Baseline and Post-Intervention (4 weeks)
Change on Scrambled Sentences Task
Time Frame: Baseline and Post-Intervention (4 weeks)
Baseline and Post-Intervention (4 weeks)
Change on Life Orientation Test - Revised
Time Frame: Baseline and Post-Intervention (4 weeks)
Baseline and Post-Intervention (4 weeks)
Change on Prospective Imagery Test
Time Frame: Baseline and Post-Intervention (4 weeks)
Baseline and Post-Intervention (4 weeks)
Change on Behavioural Activation in Depression Scale
Time Frame: Baseline and Post-Intervention (4 weeks)
Baseline and Post-Intervention (4 weeks)
Change in IAPT Toolkit
Time Frame: Baseline and Post-Intervention (4 weeks)
Includes the GAD-7, PHQ-9 and Work and Social Adjustment Scale
Baseline and Post-Intervention (4 weeks)
Change on EuroQol-5D
Time Frame: Baseline and Post-Intervention (4 weeks)
Baseline and Post-Intervention (4 weeks)
Change in Neuroticism
Time Frame: Baseline and Post-Intervention (4 weeks)
Baseline and Post-Intervention (4 weeks)
Change on Beck Depression Inventory - II
Time Frame: Baseline and Follow-Up (one month, three months, six months)
Baseline and Follow-Up (one month, three months, six months)
Change on Quick Inventory of Depressive Symptoms - Self Report
Time Frame: Baseline and Follow-Up (one month, three months, six months)
Baseline and Follow-Up (one month, three months, six months)
Change on State-Trait Anxiety Inventory (Trait scale)
Time Frame: Baseline and Follow-Up (one month, three months, six months)
Baseline and Follow-Up (one month, three months, six months)
Change on Beck Anxiety Inventory
Time Frame: Baseline and Follow-Up (one month, three months, six months)
Baseline and Follow-Up (one month, three months, six months)
Change on Life Orientation Test - Revised
Time Frame: Baseline and Follow-Up (one month, three months, six months)
Baseline and Follow-Up (one month, three months, six months)
Change on Prospective Imagery Test
Time Frame: Baseline and Follow-Up (one month, three months, six months)
Baseline and Follow-Up (one month, three months, six months)
Change on Behavioural Activation in Depression Scale
Time Frame: Baseline and Follow-Up (one month, three months, six months)
Baseline and Follow-Up (one month, three months, six months)
Change on IAPT Toolkit
Time Frame: Baseline and Follow-Up (one month, three months, six months)
Includes GAD-7, PHQ-9, Work and Social Adjustment Scale
Baseline and Follow-Up (one month, three months, six months)
Change on Euroqol-5D
Time Frame: Baseline and Follow-Up (one month, three months, six months)
Baseline and Follow-Up (one month, three months, six months)
Change on Neuroticism
Time Frame: Baseline and Follow-Up (one month, three months, six months)
Baseline and Follow-Up (one month, three months, six months)
Image Generation Task
Time Frame: Post-Intervention (4 weeks)
Task adapted from Sharot et al. (2007, Nature)
Post-Intervention (4 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Emily A Holmes, D.Clin.Psy, PhD, University of Oxford

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

April 1, 2013

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

September 27, 2011

First Submitted That Met QC Criteria

September 28, 2011

First Posted (Estimate)

September 29, 2011

Study Record Updates

Last Update Posted (Estimate)

January 9, 2014

Last Update Submitted That Met QC Criteria

January 8, 2014

Last Verified

June 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • 11/SC/0278

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on OxIGen

Subscribe